S&P 500   4,283.06 (+0.36%)
DOW   33,755.37 (+0.27%)
QQQ   352.75 (+1.13%)
AAPL   179.33 (+0.85%)
MSFT   326.41 (+0.94%)
META   266.90 (+1.25%)
GOOGL   122.88 (+0.31%)
AMZN   125.60 (+3.60%)
TSLA   232.62 (+3.58%)
NVDA   384.19 (+2.52%)
NIO   7.68 (-1.03%)
BABA   86.92 (+1.92%)
AMD   121.00 (+2.69%)
T   15.93 (-1.06%)
F   13.51 (-0.59%)
MU   65.03 (-3.03%)
CGC   0.71 (-2.34%)
GE   106.75 (+0.63%)
DIS   92.08 (-0.48%)
AMC   4.62 (-2.33%)
PFE   39.05 (+0.41%)
PYPL   64.59 (+0.86%)
NFLX   405.73 (+1.49%)
S&P 500   4,283.06 (+0.36%)
DOW   33,755.37 (+0.27%)
QQQ   352.75 (+1.13%)
AAPL   179.33 (+0.85%)
MSFT   326.41 (+0.94%)
META   266.90 (+1.25%)
GOOGL   122.88 (+0.31%)
AMZN   125.60 (+3.60%)
TSLA   232.62 (+3.58%)
NVDA   384.19 (+2.52%)
NIO   7.68 (-1.03%)
BABA   86.92 (+1.92%)
AMD   121.00 (+2.69%)
T   15.93 (-1.06%)
F   13.51 (-0.59%)
MU   65.03 (-3.03%)
CGC   0.71 (-2.34%)
GE   106.75 (+0.63%)
DIS   92.08 (-0.48%)
AMC   4.62 (-2.33%)
PFE   39.05 (+0.41%)
PYPL   64.59 (+0.86%)
NFLX   405.73 (+1.49%)
S&P 500   4,283.06 (+0.36%)
DOW   33,755.37 (+0.27%)
QQQ   352.75 (+1.13%)
AAPL   179.33 (+0.85%)
MSFT   326.41 (+0.94%)
META   266.90 (+1.25%)
GOOGL   122.88 (+0.31%)
AMZN   125.60 (+3.60%)
TSLA   232.62 (+3.58%)
NVDA   384.19 (+2.52%)
NIO   7.68 (-1.03%)
BABA   86.92 (+1.92%)
AMD   121.00 (+2.69%)
T   15.93 (-1.06%)
F   13.51 (-0.59%)
MU   65.03 (-3.03%)
CGC   0.71 (-2.34%)
GE   106.75 (+0.63%)
DIS   92.08 (-0.48%)
AMC   4.62 (-2.33%)
PFE   39.05 (+0.41%)
PYPL   64.59 (+0.86%)
NFLX   405.73 (+1.49%)
S&P 500   4,283.06 (+0.36%)
DOW   33,755.37 (+0.27%)
QQQ   352.75 (+1.13%)
AAPL   179.33 (+0.85%)
MSFT   326.41 (+0.94%)
META   266.90 (+1.25%)
GOOGL   122.88 (+0.31%)
AMZN   125.60 (+3.60%)
TSLA   232.62 (+3.58%)
NVDA   384.19 (+2.52%)
NIO   7.68 (-1.03%)
BABA   86.92 (+1.92%)
AMD   121.00 (+2.69%)
T   15.93 (-1.06%)
F   13.51 (-0.59%)
MU   65.03 (-3.03%)
CGC   0.71 (-2.34%)
GE   106.75 (+0.63%)
DIS   92.08 (-0.48%)
AMC   4.62 (-2.33%)
PFE   39.05 (+0.41%)
PYPL   64.59 (+0.86%)
NFLX   405.73 (+1.49%)
NASDAQ:PETS

PetMed Express (PETS) Stock Forecast, Price & News

$15.33
-0.32 (-2.04%)
(As of 11:10 AM ET)
Compare
Today's Range
$15.24
$15.65
50-Day Range
$14.61
$16.56
52-Week Range
$14.05
$24.01
Volume
84,891 shs
Average Volume
423,792 shs
Market Capitalization
$324.54 million
P/E Ratio
766.88
Dividend Yield
7.83%
Price Target
$18.50

PetMed Express MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
18.2% Upside
$18.50 Price Target
Short Interest
Bearish
22.20% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.24mentions of PetMed Express in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.91%
From $0.55 to $0.61 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.70 out of 5 stars

Retail/Wholesale Sector

148th out of 208 stocks

Drug Stores & Proprietary Stores Industry

3rd out of 6 stocks


PETS stock logo

About PetMed Express (NASDAQ:PETS) Stock

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Stock News Headlines

Chewy.com Gets A Mouthful Of Profits: Shares Surge, More To Come (PETS)
Chewy.com gave the market what it wanted and now the shares are surging. Short interest may drive volatility bt the reversal is on.
PetMed Express: Charts Say This Could Be The Bottom 
PetMed Express has a high 8% yield that comes with risk. The company is on track with a turnaround, and the institutions have been buying.
Graphite Shortage Could Derail the $7 Trillion EV Transition
Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.
PetMed Express: Dividend Insights
Graphite Shortage Could Derail the $7 Trillion EV Transition
Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.
PetMed Skids on Q4 Disappointment
Q4 2022 Petmed Express Inc Earnings Call
PetMed Express (NASDAQ:PETS) Releases Earnings Results
PetMed Express Inc. Q4 Earnings Summary
2 Stocks to Watch on a Quiet Market Day
PetMed Express (NASDAQ:PETS) Now Covered by StockNews.com
PetMed Express (PETS) to Release Earnings on Monday
See More Headlines

PETS Price History

PETS Company Calendar

Last Earnings
5/22/2023
Ex-Dividend for 6/12 Dividend
6/05/2023
Today
6/08/2023
Dividend Payable
6/12/2023
Next Earnings (Estimated)
7/24/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
219
Year Founded
1996

Price Target and Rating

Average Stock Price Forecast
$18.50
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+18.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$230,000.00
Pretax Margin
0.62%

Debt

Sales & Book Value

Annual Sales
$256.86 million
Cash Flow
$0.56 per share
Book Value
$5.87 per share

Miscellaneous

Free Float
20,303,000
Market Cap
$331.31 million
Optionable
Optionable
Beta
0.63

Social Links


Key Executives

  • Matthew N. Hulett
    President, Chief Executive Officer & Director
  • Christine Chambers
    Chief Financial Officer & Treasurer
  • Mark Moseley
    Chief Technology & Information Officer
  • Eddie Khoriaty
    Dir-Pharmacy Services & Prescription Dept. Manager
  • Dan Pingree
    Chief Marketing Officer













PETS Stock - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings
or view top-rated stocks.

What is PetMed Express' stock price forecast for 2023?

2 analysts have issued 12-month price objectives for PetMed Express' shares. Their PETS share price forecasts range from $17.00 to $20.00. On average, they predict the company's share price to reach $18.50 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for PETS
or view top-rated stocks among Wall Street analysts.

How have PETS shares performed in 2023?

PetMed Express' stock was trading at $17.70 at the beginning of 2023. Since then, PETS stock has decreased by 11.6% and is now trading at $15.65.
View the best growth stocks for 2023 here
.

When is PetMed Express' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 24th 2023.
View our PETS earnings forecast
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings data on Monday, May, 22nd. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of $0.14 by $0.39. The company earned $62.41 million during the quarter, compared to the consensus estimate of $69.93 million. PetMed Express had a net margin of 0.09% and a trailing twelve-month return on equity of 4.90%. During the same quarter last year, the company earned $0.30 earnings per share.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express declared a quarterly dividend on Monday, May 22nd. Stockholders of record on Tuesday, June 6th will be paid a dividend of $0.30 per share on Monday, June 12th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.67%. The ex-dividend date is Monday, June 5th.
Read our dividend analysis for PETS
.

Is PetMed Express a good dividend stock?

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.18%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 6,003.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 196.72% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.37%), State Street Corp (4.74%), Renaissance Technologies LLC (4.59%), Mirae Asset Global Investments Co. Ltd. (3.32%), Dimensional Fund Advisors LP (3.15%) and ProShare Advisors LLC (2.65%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetMed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $15.65.

How much money does PetMed Express make?

PetMed Express (NASDAQ:PETS) has a market capitalization of $331.31 million and generates $256.86 million in revenue each year. The company earns $230,000.00 in net income (profit) each year or $0.02 on an earnings per share basis.

How many employees does PetMed Express have?

The company employs 219 workers across the globe.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.

This page (NASDAQ:PETS) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -